Delivery Order SPE2DB22D2005-SPE2DB25FJEC4

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,059 firm-fixed-price delivery order is for the supply of 4,566,134,691 units of Ketamine 500 mg/5 ml vials. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,693.02 firm fixed-price delivery order is for the supply of 4558121080 - Ketamine 500 mg/5 ml vials. The contract has an ultimate completion date of August 17, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,037.55 firm-fixed-price delivery order is for the supply of Ketalar (ketamine hydrochloride) 200 mg/20 ml vials with a period of performance through November 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,194.69, is for the delivery of 4564670187 - Ketamine 500 mg/10 ml vial, 10 ml. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, with a ceiling value of $2,256.35, is for the delivery of 200 mg/20 ml vials of the drug Ketamine. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 23, 2025. The contract was awarded on January 22, 2025 and does not have a set-aside designation,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567530723 KETAMINE 500 MG/5 ML VIAL 5ML. The award has a ceiling value of $1,020.83 and is a firm fixed price delivery order contract with a completion date of March 12, 2025. The contract is not designated under any set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,499.84 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/mL vials, a pain medication. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,454.70 firm fixed-price delivery order contract is for the supply of Ketorolac 30 mg/ml vials, a pain management medication. The contract has an ultimate completion date of December 31, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a $2,153.16 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567900462 - KETAMINE 500MG/5ML 10S, a medical product. The contract has an ultimate completion date of April 15, 2025 and was awarded on April 14, 2025. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,051 to Amerisourcebergen Drug Corporation to provide 200mg/20ml vials of ketamine. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the ketamine from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements by July 18, 2023 under the parent company Amerisourcebergen Corporation. The Defense Logistics Agency functions to support the resupply needs of the...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJEC4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,650.06 fixed-price delivery order is for the supply of 200 mg/20 mL vials of the medication ketamine. The contract has an ultimate completion date of October 29, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 2/2/25, 12:04 AM